Dr. Adam Lodge, PhDAssociate Director, Research at Iksuda TherapeuticsSpeaker
Agenda Sessions
Designing Best in Class Antibody-drug Conjugates (ADCs) for the Treatment of Cancer
, 08:50View Session
